ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

News from the ECOG-ACRIN Cancer Research Group
April 24, 2025
Dr. O'Dwyer and Dr. Schnall
April 24, 2025
Categories
  • From the Co-Chairs

From the Co-Chairs, April 2025

An update on the Group's activity; a new Central Biorepository and Pathology Facility director; a preview of key Group Meeting sessions
Do you like it?
0 Read more
April 24, 2025
April 24, 2025
Categories
  • Active Clinical Trials

Amended Trial: Gelareh Sadigh and Ilana Graetz Give an Update on the EAQ221CD/CONCURxP Trial for Patients with Breast Cancer

The changes broaden eligibility for this cancer care delivery study, which aims to improve medication adherence for patients with breast cancer
Do you like it?
0 Read more
April 24, 2025
Young Black woman on laptop
April 24, 2025
Categories
  • Active Clinical Trials

Trial Spotlight: A Closer Look at ECOG-ACRIN’s Studies for Adolescents and Young Adults with Cancer

These two trials are open and enrolling adolescent and young adult survivors and patients with cancer
Do you like it?
0 Read more
April 24, 2025
April 24, 2025
Categories
  • Institution Spotlights

Institution Spotlight: Stanford Cancer Institute

A Standing Main Member of ECOG-ACRIN since 1990
Do you like it?
0 Read more
April 24, 2025
Research definition
April 24, 2025
Categories
  • Trial Results

Trial Results: ECOG-ACRIN Research Round-Up

Summaries of recently published ECOG-ACRIN research results
Do you like it?
0 Read more
April 24, 2025
News in Brief
April 24, 2025
Categories
  • News in Brief

News in Brief, April 2025

Summaries and links to timely information about research results presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org

Tags

Acute lymphoblastic leukemia (ALL) Advanced practice providers Advocacy ASCO Breast cancer Cancer care delivery research Cancer control Cancer screening Cancer surveillance Chemotherapy Clinical trials Colorectal cancer Comis Symposium Communication COVID-19 Diversity GI cancer Group Meeting Head and neck cancer Head and neck squamous cell carcinoma Health equity Immunotherapy In memory Kidney cancer Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Myeloma NCI NCI-MATCH NCORP Non-small cell lung cancer Pancreatic cancer Precision medicine Prostate cancer Real-world data Research results Sarcoma Social determinants of health Survivorship Targeted therapy TMIST
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc